[1]
Reich , K., Armstrong , A., Zhu, Y., Miller, M. , You, Y., Shen, Y.-K. , Yang, Y.-W., Foley, P., Griffiths, C. and Strober , B. 2022. Immunogenicity of Guselkumab (GUS) Among Psoriasis Patients in VOYAGE (VOY) 1&2 Studies. SKIN The Journal of Cutaneous Medicine. 6, 2 (Mar. 2022), s11. DOI:https://doi.org/10.25251/skin.6.supp.11.